Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections.

Lee GC, Hall RG, Boyd NK, Dallas SD, Du LC, Treviño LB, Treviño SB, Retzloff C, Lawson KA, Wilson J, Olsen RJ, Wang Y, Frei CR.

Ann Clin Microbiol Antimicrob. 2016 Nov 22;15(1):58.

2.

Predictors of community-associated Staphylococcus aureus, methicillin-resistant and methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in primary-care settings.

Lee GC, Hall RG, Boyd NK, Dallas SD, DU LC, Treviño LB, Retzloff C, Treviño SB, Lawson KA, Wilson JP, Olsen RJ, Wang Y, Frei CR.

Epidemiol Infect. 2016 Nov;144(15):3198-3204.

PMID:
27489019
3.

Bicyclic heterocyclic anthranilic diamides as ryanodine receptor modulators with insecticidal activity.

Jeanguenat A, Durieux P, Edmunds AJ, Hall RG, Hughes D, Loiseleur O, Pabba J, Stoller A, Trah S, Wenger J, Dutton A, Crossthwaite A.

Bioorg Med Chem. 2016 Feb 1;24(3):403-27. doi: 10.1016/j.bmc.2015.11.035.

PMID:
26688073
4.

Dosing of antifungal agents in obese people.

Payne KD, Hall RG.

Expert Rev Anti Infect Ther. 2016;14(2):257-67. doi: 10.1586/14787210.2016.1128822. Review.

PMID:
26641135
5.

Evolving Larger: Dosing Anti-Tuberculosis (TB) Drugs in an Obese World.

Hall RG 2nd.

Curr Pharm Des. 2015;21(32):4748-51. Review.

PMID:
26112269
6.

Treatment of community-acquired pneumonia.

Lee YR, Houngue C, Hall RG.

Expert Rev Anti Infect Ther. 2015;13(9):1109-21. doi: 10.1586/14787210.2015.1060125. Review.

PMID:
26091895
7.

Profile of tedizolid phosphate and its potential in the treatment of acute bacterial skin and skin structure infections.

Hall RG 2nd, Michaels HN.

Infect Drug Resist. 2015 Apr 22;8:75-82. doi: 10.2147/IDR.S56691. Review.

8.

Development of a Control Strategy for Benzene Impurity in HPMCAS-Stabilized Spray-Dried Dispersion Drug Products Using a Science-Based and Risk-Based Approach.

Yue H, Nicholson SJ, Young JD, Hsieh D, Ketner RJ, Hall RG, Sackett J, Banks EC, Castoro JA, Randazzo ME.

Pharm Res. 2015 Aug;32(8):2636-48. doi: 10.1007/s11095-015-1649-7.

PMID:
25724159
9.

In silico-derived bedside formula for individualized micafungin dosing for obese patients in the age of deterministic chaos.

Pasipanodya JP, Hall RG 2nd, Gumbo T.

Clin Pharmacol Ther. 2015 Mar;97(3):292-7. doi: 10.1002/cpt.38.

PMID:
25670351
10.

Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistant Staphylococcus aureus bacteraemia.

Hall RG 2nd, Blaszczyk AT, Thompson KA, Brouse SD, Giuliano CA, Frei CR, Forcade NA, Mortensen EM, Bell T, Bedimo RJ, Alvarez CA.

J Clin Pharm Ther. 2014 Dec;39(6):653-7. doi: 10.1111/jcpt.12203.

11.

Dosing of antibacterial agents in obese adults: does one size fit all?

Payne KD, Hall RG 2nd.

Expert Rev Anti Infect Ther. 2014 Jul;12(7):829-54. doi: 10.1586/14787210.2014.912942. Review.

PMID:
24809811
12.

Empiric weight-based vancomycin in intensive care unit patients with methicillin-resistant Staphylococcus aureus bacteremia.

Alvarez CA, Giuliano CA, Haase KK, Thompson KA, Frei CR, Forcade NA, Brouse SD, Mortensen EM, Bell T, Bedimo RJ, Toups NM, Hall RG 2nd.

Am J Med Sci. 2014 Nov;348(5):371-6. doi: 10.1097/MAJ.0000000000000262.

13.

Therapy duration and long-term outcomes in extra-pulmonary tuberculosis.

Pusch T, Pasipanodya JG, Hall RG 2nd, Gumbo T.

BMC Infect Dis. 2014 Mar 1;14:115. doi: 10.1186/1471-2334-14-115.

14.

Dosing considerations for obese patients receiving cancer chemotherapeutic agents.

Hall RG 2nd, Jean GW, Sigler M, Shah S.

Ann Pharmacother. 2013 Dec;47(12):1666-74. doi: 10.1177/1060028013509789. Review.

PMID:
24259627
15.

Weight drives caspofungin pharmacokinetic variability in overweight and obese people: fractal power signatures beyond two-thirds or three-fourths.

Hall RG 2nd, Swancutt MA, Meek C, Leff R, Gumbo T.

Antimicrob Agents Chemother. 2013 May;57(5):2259-64. doi: 10.1128/AAC.01490-12.

16.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA.

BMC Pharmacol Toxicol. 2013 Feb 13;14:12. doi: 10.1186/2050-6511-14-12.

17.

Investigating the mode of action of sulfoxaflor: a fourth-generation neonicotinoid.

Cutler P, Slater R, Edmunds AJ, Maienfisch P, Hall RG, Earley FG, Pitterna T, Pal S, Paul VL, Goodchild J, Blacker M, Hagmann L, Crossthwaite AJ.

Pest Manag Sci. 2013 May;69(5):607-19. doi: 10.1002/ps.3413.

PMID:
23112103
18.

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell T, Bedimo RJ, Alvarez CA.

BMC Infect Dis. 2012 Apr 27;12:104. doi: 10.1186/1471-2334-12-104.

19.

Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people.

Hall RG 2nd, Swancutt MA, Meek C, Leff RD, Gumbo T.

Antimicrob Agents Chemother. 2012 Mar;56(3):1502-7. doi: 10.1128/AAC.05623-11.

20.

Community-wide assessment of protein-interface modeling suggests improvements to design methodology.

Fleishman SJ, Whitehead TA, Strauch EM, Corn JE, Qin S, Zhou HX, Mitchell JC, Demerdash ON, Takeda-Shitaka M, Terashi G, Moal IH, Li X, Bates PA, Zacharias M, Park H, Ko JS, Lee H, Seok C, Bourquard T, Bernauer J, Poupon A, Azé J, Soner S, Ovali SK, Ozbek P, Tal NB, Haliloglu T, Hwang H, Vreven T, Pierce BG, Weng Z, Pérez-Cano L, Pons C, Fernández-Recio J, Jiang F, Yang F, Gong X, Cao L, Xu X, Liu B, Wang P, Li C, Wang C, Robert CH, Guharoy M, Liu S, Huang Y, Li L, Guo D, Chen Y, Xiao Y, London N, Itzhaki Z, Schueler-Furman O, Inbar Y, Potapov V, Cohen M, Schreiber G, Tsuchiya Y, Kanamori E, Standley DM, Nakamura H, Kinoshita K, Driggers CM, Hall RG, Morgan JL, Hsu VL, Zhan J, Yang Y, Zhou Y, Kastritis PL, Bonvin AM, Zhang W, Camacho CJ, Kilambi KP, Sircar A, Gray JJ, Ohue M, Uchikoga N, Matsuzaki Y, Ishida T, Akiyama Y, Khashan R, Bush S, Fouches D, Tropsha A, Esquivel-Rodríguez J, Kihara D, Stranges PB, Jacak R, Kuhlman B, Huang SY, Zou X, Wodak SJ, Janin J, Baker D.

J Mol Biol. 2011 Nov 25;414(2):289-302. doi: 10.1016/j.jmb.2011.09.031.

Items per page

Supplemental Content

Support Center